{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T08:57:01Z","timestamp":1783241821126,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018553","name":"Science and Technology Plan Project of Wenzhou","doi-asserted-by":"crossref","award":["Y20210725"],"award-info":[{"award-number":["Y20210725"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Medical and Health Science and Technology Plan Project","award":["2022KY903"],"award-info":[{"award-number":["2022KY903"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The significance of tumor-secreted cytokines in tumor development has gained substantial attention. Nevertheless, the precise role of tumor-related inflammatory cytokines in prostate cancer (PCa) remains ambiguous.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To gain deeper insights into the inflammatory response in the process of PCa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 233 cases were collected, including 80 cases of prostate hyperplasia as disease control, 65 cases of postoperative prostate cancer and 36 cases of prostate cancer as PCa group. Additionally, 52 patients undergoing physical examinations during the same period were collected as the healthy control. The levels of 12 inflammatory cytokines in peripheral blood samples were analyzed using flow cytometric bead array technology. The levels of total prostate-specific antigen (TPSA) and free prostate-specific antigen (FPSA) in peripheral blood samples were analyzed using electrochemiluminescence technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our findings revealed significant increases in serum IL-8 levels in PCa group compared to the healthy control group. Additionally, IL-6, IL-10, IFN-\u03b3 and IL-12p70 levels were markedly elevated in the PCa group compared to the disease control group (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Conversely, the level of IL-4, TNF-\u03b1, IL-1\u03b2, IL-17A and IFN-\u03b1 were lower in the PCa group compared to those in control group. Following surgery, the concentration of IL-6 decreased; whereas, the concentrations of IL-4, TNF-\u03b1, IL-17A, IL-1\u03b2, IL-12p70, and IFN-\u03b1 increased, demonstrating significant differences\n                      <jats:italic>(p<\/jats:italic>\n                      \u2009&lt;\u20090.05). The differential upregulation of IL-6 or downregulation of IL-17A in peripheral blood exhibited diagnostic efficacy in PCa patients. Moreover, we observed a significant increase in IL-17A levels, accompanied by decreased of IL-2, IL-4, IL-10, TNF-a, IFN-\u03b3, IL-1\u03b2, and IL-12P70 in patients with distant metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The peripheral blood cytokines are closely associated with the occurrence and development of prostate cancer, especially the serum levels of IL-6 and IL-17A may be useful as potential predictors of PCa diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00262-024-03723-4","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T09:10:44Z","timestamp":1717492244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the clinical application value of cytokine expression profiles in the differential diagnosis of prostate cancer"],"prefix":"10.1007","volume":"73","author":[{"given":"Rongfa","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"3723_CR1","doi-asserted-by":"publisher","first-page":"647110","DOI":"10.3389\/fonc.2021.647110","volume":"11","author":"K Chen","year":"2021","unstructured":"Chen K, Jiang K, Tang L, Chen X, Hu J, Sun F (2021) Analysis of clinical trials on therapies for prostate cancer in mainland china and globally from 2010 to 2020. Front Oncol 11:647110. https:\/\/doi.org\/10.3389\/fonc.2021.647110","journal-title":"Front Oncol"},{"key":"3723_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"3723_CR3","doi-asserted-by":"publisher","first-page":"1175513","DOI":"10.3389\/fimmu.2023.1175513","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Chen F, Gao H et al (2023) Cytokine concentration in peripheral blood of patients with colorectal cancer. Front Immunol 14:1175513. https:\/\/doi.org\/10.3389\/fimmu.2023.1175513","journal-title":"Front Immunol"},{"key":"3723_CR4","doi-asserted-by":"publisher","first-page":"E592","DOI":"10.1073\/pnas.1318157111","volume":"111","author":"OJ Kwon","year":"2014","unstructured":"Kwon OJ, Zhang L, Ittmann MM, Xin L (2014) Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin. Proc Natl Acad Sci USA 111:E592-600. https:\/\/doi.org\/10.1073\/pnas.1318157111","journal-title":"Proc Natl Acad Sci USA"},{"key":"3723_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/149185","author":"G Landskron","year":"2014","unstructured":"Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. https:\/\/doi.org\/10.1155\/2014\/149185","journal-title":"J Immunol Res"},{"key":"3723_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1186\/s12885-017-3879-z","volume":"17","author":"KQ Yang","year":"2017","unstructured":"Yang KQ, Liu Y, Huang QH, Mo N, Zhang QY, Meng QG, Cheng JW (2017) Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth. BMC Cancer 17:878. https:\/\/doi.org\/10.1186\/s12885-017-3879-z","journal-title":"BMC Cancer"},{"key":"3723_CR7","doi-asserted-by":"publisher","first-page":"114316","DOI":"10.1016\/j.bcp.2020.114316","volume":"183","author":"M Carty","year":"2021","unstructured":"Carty M, Guy C, Bowie AG (2021) Detection of viral infections by innate immunity. Biochem Pharmacol 183:114316. https:\/\/doi.org\/10.1016\/j.bcp.2020.114316","journal-title":"Biochem Pharmacol"},{"key":"3723_CR8","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.psj.2019.12.011","volume":"99","author":"MH Kogut","year":"2020","unstructured":"Kogut MH, Lee A, Santin E (2020) Microbiome and pathogen interaction with the immune system. Poult Sci 99:1906\u20131913. https:\/\/doi.org\/10.1016\/j.psj.2019.12.011","journal-title":"Poult Sci"},{"key":"3723_CR9","doi-asserted-by":"publisher","first-page":"107087","DOI":"10.1016\/j.intimp.2020.107087","volume":"89","author":"V Kumar","year":"2020","unstructured":"Kumar V (2020) Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol 89:107087. https:\/\/doi.org\/10.1016\/j.intimp.2020.107087","journal-title":"Int Immunopharmacol"},{"key":"3723_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40880-017-0198-3","volume":"36","author":"J Dai","year":"2017","unstructured":"Dai J, Lu Y, Roca H, Keller JM, Zhang J, McCauley LK, Keller ET (2017) Immune mediators in the tumor microenvironment of prostate cancer. Chin J Cancer 36:29. https:\/\/doi.org\/10.1186\/s40880-017-0198-3","journal-title":"Chin J Cancer"},{"key":"3723_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/pros.23990","volume":"80","author":"S Liu","year":"2020","unstructured":"Liu S, Liu F, Zhang B et al (2020) CD4(+) T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion. Prostate 80:764\u2013776. https:\/\/doi.org\/10.1002\/pros.23990","journal-title":"Prostate"},{"key":"3723_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/fcp.12517","volume":"34","author":"Y Liu","year":"2020","unstructured":"Liu Y, Mikrani R, Xie D et al (2020) Chronic prostatitis\/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines. Fundam Clin Pharmacol 34:160\u2013172. https:\/\/doi.org\/10.1111\/fcp.12517","journal-title":"Fundam Clin Pharmacol"},{"key":"3723_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2017.02.006","volume":"184","author":"X Wang","year":"2017","unstructured":"Wang X, Yang L, Huang F, Zhang Q, Liu S, Ma L, You Z (2017) Inflammatory cytokines IL-17 and TNF-\u03b1 up-regulate PD-L1 expression in human prostate and colon cancer cells. Immunol Lett 184:7\u201314. https:\/\/doi.org\/10.1016\/j.imlet.2017.02.006","journal-title":"Immunol Lett"},{"key":"3723_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12967-022-03731-x","volume":"20","author":"I Deichaite","year":"2022","unstructured":"Deichaite I, Sears TJ, Sutton L et al (2022) Differential regulation of TNF\u03b1 and IL-6 expression contributes to immune evasion in prostate cancer. J Transl Med 20:527. https:\/\/doi.org\/10.1186\/s12967-022-03731-x","journal-title":"J Transl Med"},{"key":"3723_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s40001-022-00807-8","volume":"27","author":"NYF Snyper","year":"2022","unstructured":"Snyper NYF, Pike J, Ekwueme K, Shergill I, Hughes SF (2022) Selective biomarkers for inflammation and infection are associated with post-operative complications following transperineal template prostate biopsy (TTPB): a single-centre observational clinical pilot-study. Eur J Med Res 27:187. https:\/\/doi.org\/10.1186\/s40001-022-00807-8","journal-title":"Eur J Med Res"},{"key":"3723_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/pros.24299","volume":"82","author":"J Zhou","year":"2022","unstructured":"Zhou J, Chen H, Wu Y, Shi B, Ding J, Qi J (2022) Plasma IL-6 and TNF-\u03b1 levels correlate significantly with grading changes in localized prostate cancer. Prostate 82:531\u2013539. https:\/\/doi.org\/10.1002\/pros.24299","journal-title":"Prostate"},{"key":"3723_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/pros.24074","volume":"80","author":"LC Harshman","year":"2020","unstructured":"Harshman LC, Wang VX, Hamid AA, Santone G, Drake CG, Carducci MA, DiPaola RS, Fichorova RN, Sweeney CJ (2020) Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805). Prostate 80:1429\u20131437. https:\/\/doi.org\/10.1002\/pros.24074","journal-title":"Prostate"},{"key":"3723_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-023-01384-3","author":"Y Ma","year":"2023","unstructured":"Ma Y, Fu Y, Fan X, Ji Q, Duan X, Wang Y, Zhang Y, Wang Z, Hao H (2023) FAK\/IL-8 axis promotes the proliferation and migration of gastric cancer cells. Gastric Cancer. https:\/\/doi.org\/10.1007\/s10120-023-01384-3","journal-title":"Gastric Cancer"},{"issue":"4","key":"3723_CR19","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/cancers15071997","volume":"15","author":"PRA Pastrez","year":"2023","unstructured":"Pastrez PRA, Barbosa AM, Mariano VS, Causin RL, Castro AG, Torrado E, Longatto-Filho A (2023) Interleukin-8 and interleukin-6 are biomarkers of poor prognosis in esophageal squamous cell carcinoma. Cancers (Basel) 15(4):1997. https:\/\/doi.org\/10.3390\/cancers15071997","journal-title":"Cancers (Basel)"},{"key":"3723_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12672-023-00641-2","volume":"14","author":"L Yi","year":"2023","unstructured":"Yi L, Wang X, Fu S, Yan Z, Ma T, Li S, Wei P, Zhang H, Wang J (2023) Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC. Discov Oncol 14:35. https:\/\/doi.org\/10.1007\/s12672-023-00641-2","journal-title":"Discov Oncol"},{"key":"3723_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.6004\/jnccn.2022.0063","volume":"20","author":"EM Schaeffer","year":"2022","unstructured":"Schaeffer EM, Srinivas S, Adra N et al (2022) NCCN guidelines\u00ae insights: prostate cancer, version 1.2023. J Natl Compr Cancer Netw JNCCN 20:1288\u20131298. https:\/\/doi.org\/10.6004\/jnccn.2022.0063","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"3723_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10:63\u201389. https:\/\/doi.org\/10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"3723_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/15384047.2015.1026476","volume":"16","author":"A Crucitti","year":"2015","unstructured":"Crucitti A, Corbi M, Tomaiuolo PM, Fanali C, Mazzari A, Lucchetti D, Migaldi M, Sgambato A (2015) Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors. Cancer Biol Ther 16:671\u2013677. https:\/\/doi.org\/10.1080\/15384047.2015.1026476","journal-title":"Cancer Biol Ther"},{"key":"3723_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR (2022) Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 19:237\u2013253. https:\/\/doi.org\/10.1038\/s41571-021-00588-9","journal-title":"Nat Rev Clin Oncol"},{"key":"3723_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028472","author":"TA Waldmann","year":"2018","unstructured":"Waldmann TA (2018) Cytokines in cancer immunotherapy. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a028472","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3723_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2217\/fon-2021-0683","volume":"18","author":"P Katongole","year":"2022","unstructured":"Katongole P, Sande OJ, Nabweyambo S et al (2022) IL-6 and IL-8 cytokines are associated with elevated prostate-specific antigen levels among patients with adenocarcinoma of the prostate at the Uganda Cancer Institute. Future Oncol 18:661\u2013667. https:\/\/doi.org\/10.2217\/fon-2021-0683","journal-title":"Future Oncol"},{"key":"3723_CR27","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.21873\/anticanres.15090","volume":"41","author":"MM Garrido","year":"2021","unstructured":"Garrido MM, Ribeiro RM, Kr\u00fcger K, Pinheiro LC, Guimar\u00e3es JT, Holdenrieder S (2021) Are proinflammatory cytokines relevant for the diagnosis of prostate cancer? Anticancer Res 41:3067\u20133073. https:\/\/doi.org\/10.21873\/anticanres.15090","journal-title":"Anticancer Res"},{"key":"3723_CR28","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/febs.16680","volume":"290","author":"M Kim","year":"2023","unstructured":"Kim M, Reidenbach S, Schlechter T, Rothmann AC, Will R, Hofmann I (2023) Plakophilin 1 deficiency in prostatic tumours is correlated with immune cell recruitment and controls the up-regulation of cytokine expression post-transcriptionally. FEBS J 290:1907\u20131919. https:\/\/doi.org\/10.1111\/febs.16680","journal-title":"FEBS J"},{"key":"3723_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006020","author":"S Chen","year":"2023","unstructured":"Chen S, Lu K, Hou Y et al (2023) YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-006020","journal-title":"J Immunother Cancer"},{"key":"3723_CR30","doi-asserted-by":"publisher","first-page":"5980387","DOI":"10.1155\/2022\/5980387","volume":"2022","author":"CV Ene","year":"2022","unstructured":"Ene CV, Nicolae I, Geavlete B, Geavlete P, Ene CD (2022) IL-6 Signaling link between inflammatory tumor microenvironment and prostatic tumorigenesis. Anal Cell Pathol (Amst) 2022:5980387. https:\/\/doi.org\/10.1155\/2022\/5980387","journal-title":"Anal Cell Pathol (Amst)"},{"key":"3723_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2023.02.083","volume":"655","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ye Y, Xu Z, Luo M, Wu C, Zhang Y, Lv S, Wei Q (2023) Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling. Biochem Biophys Res Commun 655:35\u201343. https:\/\/doi.org\/10.1016\/j.bbrc.2023.02.083","journal-title":"Biochem Biophys Res Commun"},{"key":"3723_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3347\/phd.22160","volume":"61","author":"IH Han","year":"2023","unstructured":"Han IH, Kim JH, Ryu JS (2023) Inflammatory response to trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia. Parasites Hosts Dis 61:2\u201314. https:\/\/doi.org\/10.3347\/phd.22160","journal-title":"Parasites Hosts Dis"},{"key":"3723_CR33","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/pros.24605","volume":"83","author":"R Yan","year":"2023","unstructured":"Yan R, Dai W, Mao Y, Yu G, Li W, Shu M, Xu B (2023) Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL-17 signaling pathway gene LCN2 in castration-resistant prostate cancer. Prostate 83:1430\u20131445. https:\/\/doi.org\/10.1002\/pros.24605","journal-title":"Prostate"},{"key":"3723_CR34","doi-asserted-by":"publisher","first-page":"110663","DOI":"10.1016\/j.cellsig.2023.110663","volume":"107","author":"M Yamaguchi","year":"2023","unstructured":"Yamaguchi M, Hashimoto K, Jijiwa M, Murata T (2023) The inflammatory macrophages repress the growth of bone metastatic human prostate cancer cells via TNF-\u03b1 and IL-6 signaling: Involvement of cell signaling regulator regucalcin. Cell Signal 107:110663. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110663","journal-title":"Cell Signal"},{"key":"3723_CR35","doi-asserted-by":"publisher","first-page":"153303382311778","DOI":"10.1177\/15330338231177809","volume":"22","author":"H Fan","year":"2023","unstructured":"Fan H, Tang Z, Tian Y, Lv Q, Zeng F (2023) IL-8 produced via bidirectional communication between prostate cancer and m2 macrophages as a potential diagnostic and prognostic biomarker. Technol Cancer Res Treat 22:15330338231177808. https:\/\/doi.org\/10.1177\/15330338231177809","journal-title":"Technol Cancer Res Treat"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03723-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-024-03723-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-024-03723-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T11:12:11Z","timestamp":1721733131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-024-03723-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3723"],"URL":"https:\/\/doi.org\/10.1007\/s00262-024-03723-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3992209\/v1","asserted-by":"object"}]},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Second Affiliated Hospital of Wenzhou Medical University, with the approval number: No: 2021-K-301-01.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided informed consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"139"}}